Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in AZN — Astrazeneca PLC

CIK 923093 STAMFORD, CT

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,517,295
+$7,517,295 QoQ
Shares Held
39,644
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#334
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Derivatives in AZN

reported options exposure · as of Jun 30, 2026
CallValue
$2,180,630
CallShares
11,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $79,702,583 across 6 Drug Manufacturers - General names. AZN ranks #5 (9.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 AZN
Astrazeneca PLC
This page
39,644 $7,517,295

All Filings in AZN

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,180,630 11,500
2026-06-30 $7,517,295 39,644
2026-03-31 $2,524,416 12,800
2026-03-31 $848,046 4,300